Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
Sebastião Freitas de Medeiros
Reviews in Endocrine and Metabolic Disorders, 2022
View PDFchevron_right
Peculiarities of COVID-19 Susceptibility in Women with Polycystic Ovary Syndrome
nadia kutna
Grail of Science
View PDFchevron_right
A nationwide cross-sectional study to analyse the impact of the COVID-19 pandemic on lifestyle and manifestations of polycystic ovarian syndrome among clinically diagnosed polycystic ovarian syndrome cases aged 15-49 years
Gneyaa Bhatt
International Journal Of Community Medicine And Public Health
View PDFchevron_right
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Dorota Doherty
The Journal of clinical endocrinology and metabolism, 2015
View PDFchevron_right
Readdressing pathophysiology of polycystic ovary syndrome in post-COVID new normal era: A pilot study
sanchari chakraborty
BOHR International Journal on Gynaecology
View PDFchevron_right
Age-Adjusted Associations Between Comorbidity and Outcomes of COVID-19: A Review of the Evidence From the Early Stages of the Pandemic
Andy Pennington
Frontiers in Public Health, 2021
View PDFchevron_right
The Influence of Different Risk Factors on COVID-19 Outcomes in Adult Patients - An Observational-Descriptive Study
Kosana Stanetic
Acta Medica Academica
View PDFchevron_right
Generational Health Impact of PCOS on Women and their Children
Roger Hart
Medical Sciences, 2019
View PDFchevron_right
Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study
Mary Ní Lochlainn
PLOS ONE, 2021
View PDFchevron_right
The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study
Ganesh Ram
Metabolism Open, 2020
View PDFchevron_right
The risk factors of COVID-19 in 50–74 years old people: a longitudinal population-based study
shahrbanoo goli
2021
View PDFchevron_right
Impact of Metabolic Syndrome on Severity of COVID-19 Illness
SHANNON SHAN WU
Metabolic Syndrome and Related Disorders, 2022
View PDFchevron_right
Morbidity and Mortality of COVID in Relation to Age, Sex and BMI
Srikrishna Karnatapu
ABC Journal of Advanced Research
View PDFchevron_right
Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population
Charles Glueck
Metabolism, 2009
View PDFchevron_right
Role of short-term estradiol supplementation in symptomatic postmenopausal COVID-19 females: A randomized controlled trial
shikha seth
Journal of Mid-life Health, 2021
View PDFchevron_right
Can the treatment of polycystic ovary syndrome with spironolactone prevent severe COVID infection?
Decio Armanini
European Journal of Endocrinology, 2022
View PDFchevron_right
Age-adjusted associations between comorbidity and outcomes of COVID-19: a review of the evidence
Andy Pennington
2020
View PDFchevron_right
Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study
Leila Cheraghi
Fertility and sterility, 2017
View PDFchevron_right
Challenges in Women with Diabetes During the COVID-19 Pandemic
Chitra Selvan
European Endocrinology
View PDFchevron_right
Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry
Maria Madeleine Rüthrich
Frontiers in Medicine
View PDFchevron_right
Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated
M. Urbanek
Fertility and Sterility, 2002
View PDFchevron_right
Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria
Zuhal Yapici
Human Reproduction, 2012
View PDFchevron_right
The prevalence of metabolic conditions before and during the COVID-19 pandemic and its association with health and sociodemographic factors
Oluwabunmi Dada
PLOS ONE
View PDFchevron_right
Demographic Characteristics & Risk Factors of Patients with Covid- 19: A Rapid Review
SOPHIA MARIE AÑO
Philippine journal of physical therapy, 2022
View PDFchevron_right
The role of adiposity, body mass index, aging and chronic comorbidities on the progression of COVID-19 illness. Is a ‘long COVID’ syndrome inevitable?
Orien Tulp
International journal of family & community medicine, 2022
View PDFchevron_right
A guide for younger generations to manage the implications of PCOS
Riya Vishwakarma
International Journal of Novel Research and Development (IJNRD), 2023
View PDFchevron_right
Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study
L. Schmidt
European Journal of Preventive Cardiology, 2020
View PDFchevron_right
Predicting Risk of Metabolic Disorders in Pcos Women
Pallavi Shettigar
2011
View PDFchevron_right
The pressing need for standardization in epidemiologic studies of PCOS across the globe
Michael Ntumy
Gynecological Endocrinology
View PDFchevron_right
Managing common endocrine disorders amid COVID-19 pandemic
sanjay bhadada
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
View PDFchevron_right
COVID-19 outcomes in postmenopausal and perimenopausal females: Is estrogen hormone attributing to gender differences?
Prabhat Agrawal
Journal of Mid-life Health, 2020
View PDFchevron_right
Consequences of the COVID-19 pandemic for patients with metabolic diseases
H. Onyegbutulem
Nature Metabolism
View PDFchevron_right
A Midwest COVID-19 Cohort for the Evaluation of Multimorbidity and Adverse Outcomes from COVID-19
Loren Toussaint
Journal of Primary Care & Community Health, 2021
View PDFchevron_right